BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

CDMOs and CROs at BIO‑Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

42 CDMOs and CROs are at BIO-Europe 2026 — 35 presentations on the program and 1 with a booth in the exhibit hall. Most represented: Evotec (2 on the program), Lonza (2 on the program), Parexel (2 on the program). 38 of them have their own page in this guide. As of Nov 10, 2026.

All 473 organizations at BIO-Europe 2026 →

Track
Top represented
Showing 1–18 of 42 organizations
OrganizationBIO-Europe 2026 Attendance
Evotec
Hamburg, Germany
◆Platinum Sponsor
CDMO & CROPlatinum sponsor
Drug discovery and development partner providing research services and biologics development and manufacturing to pharma and biotech.
Panel
Tue Nov 10
17:00–17:45
Resilient by Design: Reinventing Biopharma Alliances in a Fragmenting World
How drug companies are reshaping research and manufacturing partnerships to stay reliable as political tensions and supply chain risks divide the world.
with Handelsblatt, Circio, Angelini Ventures +1 more
Business of BiotechBiomanufacturing Strategy
Panel
Wed Nov 11
11:00–12:00
Collaborative Innovation in CDMO Partnerships
How drug companies and contract manufacturers develop new therapies together, with examples of what makes these partnerships work and where they struggle.
with Eleva, Bayer
Lonza
Basel, Switzerland
◆Platinum Sponsor
CDMO & CROPlatinum sponsor
Contract development and manufacturing organization for biologics, small molecules, and cell and gene therapies.
Talk
Mon Nov 9
15:30–15:55
Beyond the Race to IND: Balancing Speed, Risk and Future Value
When racing to first human trials pays off for a biotech, and when that speed creates risks for manufacturing and growth later on.
Panel
Tue Nov 10
15:00–15:25
Scaling Biologics Manufacturing in a Changing World: How Biopharma is Rethinking Launches, Partnerships and Resilience
How political uncertainty and trade shifts are changing how drug companies pick outside manufacturers, including whether to produce closer to home.
with BioSpace
Parexel
Durham, NC
◆Platinum Sponsor
CDMO & CROPlatinum sponsor
Clinical research organization providing clinical development, regulatory consulting and market access services to biopharmaceutical companies.
Panel
Tue Nov 10
14:00–14:25
Navigating the Evolving Regulatory Landscape: Strategies for Clinical Success in an Era of Transformation
How rare disease drugs can win approval with few patients, how FDA leadership changes shift priorities, and how real-world data can strengthen applications.
with AOP Health
Panel
Tue Nov 10
16:00–16:45
Unlocking Clinical Trial Systems
How EU clinical trial rules and a planned EU biotech law affect trial approval times, and whether Europe can speed up safely.
with R Kupiec Consulting, Merck KGaA, AstraZeneca
FC
FGK Clinical Research
Munich, Germany
CDMO & CRO
German contract research organization running clinical trials for pharma, biotech and medical device companies.
Panel
Mon Nov 9
14:30–14:55
Cracking the Translation Gap: Lessons from Germany’s Coordinated Translational Research Model
How Germany's coordinated network of health research centres can help turn lab discoveries into therapies and startups, and what stands in the way.
with German Centers for Health Research (DZG), Viacure
Panel
Tue Nov 10
09:30–09:55
Biopharma Ecosystem Germany: Spotlight on Innovation Drivers Ready for Take-Off
Five teams from Germany's biotech scene, which spans university research, companies, drug manufacturing and healthcare, show their work and its impact.
with Germany Trade & Invest, Rentschler Biopharma, CD4 Therapeutics +1 more
CDMO & CRO
Not-for-profit first-in-human Phase 1 clinical trial unit in the Randwick health precinct, also running later-phase oncology and haematology trials.
Panel
Tue Nov 10
14:30–15:00
Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic
Why Australia suits a drug's first trials in people, with supportive rules, engaged doctors and data that European and US regulators accept.
with MaH Clinical Trial Solutions, Agilex Biolabs, BioCina +1 more
BeNatureBioLab
Chuncheon, South Korea
CDMO & CRO
Provides formulation development and contract manufacturing for functional foods, cosmetics and pharmaceuticals using hot-melt extrusion drug delivery technology.
Panel
Tue Nov 10
14:00–14:30
Korea's Next Wave: Biotech Innovators to Watch
Korean biotechs present work spanning drug formulation, safety testing, the microbiome, mRNA and gene therapy delivery, and engineered toxins for cosmetic use.
with Startup Colors, Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), Cellweaverse +3 more
Talk
Wed Nov 11
09:50–10:00
Drug Delivery: BeNatureBioLab
A Korean university spin-off's solvent-free hot-melt extrusion process that helps poorly soluble drugs dissolve and get absorbed when taken by mouth.
◆Gold Sponsor
CDMO & CROGold sponsor
Biologics contract development and manufacturing organization formed from Polpharma Biologics, with GMP facilities in Gdansk and near Warsaw.
Talk
Tue Nov 10
13:00–14:00
Biologics Manufacturing Excellence
How makers of biologics, drugs made in living cells, can expand capacity, clear production bottlenecks and use new technology to work more efficiently.
with Immatics, Boehringer Ingelheim, ValiRx +1 more
Syneos Health
Morrisville, NC
◆Platinum Sponsor
CDMO & CROPlatinum sponsor
Contract research and commercialization organization supporting biopharmaceutical companies from clinical development to launch.
Panel
Mon Nov 9
13:00–14:00
Navigating partnering and business development in a shifting global landscape
How funding conditions, treatment trends and geopolitics are shaping partnerships and acquisitions between drug and biotech companies, with real deal examples.
with Biogen, Genmab, Astellas +2 more
WuXi AppTec
Shanghai, China
◆Platinum Sponsor
CDMO & CROPlatinum sponsor
Contract research, development and manufacturing organization serving pharma and biotech across small molecules, oligonucleotides, peptides and other modalities.
Panel
Tue Nov 10
17:00–17:45
Resilient by Design: Reinventing Biopharma Alliances in a Fragmenting World
How drug companies are reshaping research and manufacturing partnerships to stay reliable as political tensions and supply chain risks divide the world.
with Handelsblatt, Circio, Angelini Ventures +1 more
Business of BiotechBiomanufacturing Strategy
AB
Agilex Biolabs
Adelaide, Australia
CDMO & CRO
Australian bioanalytical laboratory providing regulated bioanalysis, toxicology and immunology testing for clinical trials.
Panel
Tue Nov 10
14:30–15:00
Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic
Why Australia suits a drug's first trials in people, with supportive rules, engaged doctors and data that European and US regulators accept.
with Scientia Clinical Research, MaH Clinical Trial Solutions, BioCina +1 more
Alithia Life Sciences
Melbourne, Australia
CDMO & CRO
Australian clinical research consultancy supporting Phase I to III trials with project and site management, monitoring and data management.
Panel
Wed Nov 11
09:55–10:25
What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad
How companies use clinical data gathered in Australia to move into multinational trials, raise investment and launch products worldwide.
with Crux Biolabs, CMAX Clinical Research, Cancer Trials Australia +1 more
Avion CRO
Melbourne, Australia
CDMO & CRO
Australian contract research organization specializing in imaging for clinical trials, including central reads, dosimetry and radiopharmaceutical studies.
Panel
Tue Nov 10
14:30–15:00
Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic
Why Australia suits a drug's first trials in people, with supportive rules, engaged doctors and data that European and US regulators accept.
with Scientia Clinical Research, MaH Clinical Trial Solutions, Agilex Biolabs +1 more
B
BioCina
Adelaide, Australia
CDMO & CRO
Australian CDMO manufacturing microbial biologics, plasmid DNA and mRNA for clinical and commercial supply.
Panel
Tue Nov 10
14:30–15:00
Accelerating First-in-Human: Why Australia is the Fast Track to the Clinic
Why Australia suits a drug's first trials in people, with supportive rules, engaged doctors and data that European and US regulators accept.
with Scientia Clinical Research, MaH Clinical Trial Solutions, Agilex Biolabs +1 more
Cancer Trials Australia
Melbourne, Australia
CDMO & CRO
Not-for-profit network of Australian and New Zealand hospital sites and research institutes providing oncology clinical trial management services.
Panel
Wed Nov 11
09:55–10:25
What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad
How companies use clinical data gathered in Australia to move into multinational trials, raise investment and launch products worldwide.
with Alithia Life Sciences, Crux Biolabs, CMAX Clinical Research +1 more
Cellistic
Mont-Saint-Guibert, Belgium
CDMO & CRO
Contract development and manufacturing organization for cell therapies derived from induced pluripotent stem cells (iPSCs).
Talk
Wed Nov 11
10:30–11:00
From Innovation to Scalable Manufacturing: Closing the Gap
Biotechs, researchers and contract manufacturers discuss what it takes to scale a new therapy into a product made reliably under strict quality rules.
with BioWin, Superbranche, Fraunhofer IZI
Clinmark
Warsaw, Poland
CDMO & CRO
Contract research and consulting organization running phase I–IV clinical trials in Central and Eastern Europe and advising on trials worldwide.
Talk
Tue Nov 10
14:45–15:00
Technologies and Tools: Clinmark
A contract research company running clinical trials for drug and device makers since 2001, with deep experience in Central and Eastern Europe.
CMAX Clinical Research
Adelaide, Australia
CDMO & CRO
Australian early-phase clinical trial unit running first-in-human and other early-phase studies for sponsors.
Panel
Wed Nov 11
09:55–10:25
What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad
How companies use clinical data gathered in Australia to move into multinational trials, raise investment and launch products worldwide.
with Alithia Life Sciences, Crux Biolabs, Cancer Trials Australia +1 more
CMIC Group
Tokyo, Japan
CDMO & CRO
Japanese contract research and manufacturing group serving drug companies, including clinical trials across Asia.
Panel
Tue Nov 10
13:00–13:55
Unlocking APACs Clinical Trials Potential: Navigating Regulatory Pathways, Bridging Strategies and Market Access Across the Region
How to run clinical trials and win approval in Japan, Korea, Taiwan and Southeast Asia, and when studies in local patients pay off.
with Graythan Regulatory Services, HiRO, Differentia Bio

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from CDMOs and CROs

Tell us what you sell and we’ll find the people at these CDMOs and CROs most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse BIO-Europe 2026 by

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction